Clinical Trial Update: Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan

View source ↗

Summary

This update reports real-world safety and efficacy data for trastuzumab deruxtecan and sacituzumab govitecan in breast cancer and metastatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan) (trastuzumab deruxtecan)
• Trodelvy (sacituzumab govitecan) (sacituzumab govitecan)

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Breast Cancer, Metastatic Cancer | Status: COMPLETED